{"id":"https://openalex.org/W4391879547","doi":"https://doi.org/10.1038/s41375-024-02178-x","title":"The UBE2J2/UBE2K-MARCH5 ubiquitination machinery regulates apoptosis in response to venetoclax in acute myeloid leukemia","display_name":"The UBE2J2/UBE2K-MARCH5 ubiquitination machinery regulates apoptosis in response to venetoclax in acute myeloid leukemia","publication_year":2024,"publication_date":"2024-02-16","ids":{"openalex":"https://openalex.org/W4391879547","doi":"https://doi.org/10.1038/s41375-024-02178-x","pmid":"https://pubmed.ncbi.nlm.nih.gov/38366087","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10912020"},"language":"en","primary_location":{"id":"doi:10.1038/s41375-024-02178-x","doi":"https://doi.org/10.1038/s41375-024-02178-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41375-024-02178-x","pdf_url":"https://www.nature.com/articles/s41375-024-02178-x.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/s41375-024-02178-x.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087496453","display_name":"Shan Lin","orcid":"https://orcid.org/0000-0002-9699-0250","observed_orcids":["https://orcid.org/0000-0002-9699-0250"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shan Lin","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA, USA","Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA, USA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109666770","display_name":"Constanze Schneider","orcid":"https://orcid.org/0009-0005-0092-5999","observed_orcids":["https://orcid.org/0009-0005-0092-5999","https://orcid.org/0009-0007-9786-150X"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constanze Schneider","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA, USA","Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA, USA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040954385","display_name":"Angela H. Su","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela H. Su","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA, USA","Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA, USA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037413866","display_name":"Gabriela Alexe","orcid":"https://orcid.org/0000-0002-5668-6297","observed_orcids":["https://orcid.org/0000-0002-5668-6297"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriela Alexe","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA, USA","Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-5668-6297","affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA, USA","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086771961","display_name":"David E. Root","orcid":"https://orcid.org/0000-0001-5122-861X","observed_orcids":["https://orcid.org/0000-0001-5122-861X"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David E. Root","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA, USA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011985711","display_name":"Kimberly Stegmaier","orcid":"https://orcid.org/0000-0003-0218-7895","observed_orcids":["https://orcid.org/0000-0003-0218-7895"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kimberly Stegmaier","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge, MA, USA. Kimberly_stegmaier@dfci.harvard.edu","Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Kimberly_stegmaier@dfci.harvard.edu","Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. Kimberly_stegmaier@dfci.harvard.edu","Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA"],"raw_orcid":"https://orcid.org/0000-0003-0218-7895","affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge, MA, USA. Kimberly_stegmaier@dfci.harvard.edu","institution_ids":["https://openalex.org/I107606265"]},{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Kimberly_stegmaier@dfci.harvard.edu","institution_ids":["https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. Kimberly_stegmaier@dfci.harvard.edu","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1288882113"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5011985711"],"corresponding_institution_ids":["https://openalex.org/I107606265","https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210134579"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":{"value":4990,"currency":"USD","value_usd":4990},"fwci":1.2206,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.76121227,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"38","issue":"3","first_page":"652","last_page":"656"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.46140000224113464,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.46140000224113464,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.3034999966621399,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.17249999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/march5","display_name":"MARCH5","score":0.9810000061988831},{"id":"https://openalex.org/keywords/ubiquitination","display_name":"ubiquitination","score":0.9179999828338623},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7310000061988831},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9869999885559082},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.953000009059906},{"id":"https://openalex.org/keywords/mitochondrial-membrane-permeabilization","display_name":"mitochondrial membrane permeabilization","score":0.6399999856948853},{"id":"https://openalex.org/keywords/venetoclax-resistance","display_name":"venetoclax resistance","score":0.796999990940094},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9536265134811401},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7767066955566406},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.593444287776947},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5888972282409668},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5340505838394165},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.493566632270813},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43487048149108887},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.41168704628944397},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4058322608470917},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3430996537208557},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1404707133769989},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12987646460533142},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.07246991991996765}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044763","descriptor_name":"Ubiquitin-Conjugating Enzymes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054875","descriptor_name":"Ubiquitination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/s41375-024-02178-x","doi":"https://doi.org/10.1038/s41375-024-02178-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41375-024-02178-x","pdf_url":"https://www.nature.com/articles/s41375-024-02178-x.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10912020","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10912020","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10912020/pdf/41375_2024_Article_2178.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Text"},{"id":"pmid:38366087","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38366087","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/s41375-024-02178-x","doi":"https://doi.org/10.1038/s41375-024-02178-x","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41375-024-02178-x","pdf_url":"https://www.nature.com/articles/s41375-024-02178-x.pdf","source":{"id":"https://openalex.org/S149476849","display_name":"Leukemia","issn_l":"0887-6924","issn":["0887-6924","1476-5551"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1162614411","display_name":null,"funder_award_id":"CA263161","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4339824153","display_name":null,"funder_award_id":"SCHN 1622/1-1","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G4697901335","display_name":null,"funder_award_id":"CA206963","funder_id":"https://openalex.org/F4320308295","funder_display_name":"Leukemia and Lymphoma Society"},{"id":"https://openalex.org/G5391537122","display_name":null,"funder_award_id":"CA263161","funder_id":"https://openalex.org/F4320306085","funder_display_name":"U.S. Department of Health and Human Services"},{"id":"https://openalex.org/G5401613061","display_name":"Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia","funder_award_id":"4r00ca263161-03","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5746865926","display_name":"Characterizing the role of MARCH5 in apoptosis regulation in acute myeloid leukemia","funder_award_id":"K99CA263161","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6342997465","display_name":null,"funder_award_id":"CA210030","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6853658425","display_name":null,"funder_award_id":"R00 CA263161","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7262171246","display_name":"SPORE in Myeloid Malignancies","funder_award_id":"P50CA206963","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7546166877","display_name":null,"funder_award_id":"CA206963","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G7680719873","display_name":null,"funder_award_id":"CA210030","funder_id":"https://openalex.org/F4320306085","funder_display_name":"U.S. Department of Health and Human Services"},{"id":"https://openalex.org/G7934329832","display_name":"Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer","funder_award_id":"R35CA210030","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000893592","display_name":"Targeting Pediatric Cancer Vulnerabilities","funder_award_id":"R35CA283977","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306085","display_name":"U.S. Department of Health and Human Services","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320308295","display_name":"Leukemia and Lymphoma Society","ror":"https://ror.org/04m0xav37"},{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391879547.pdf","grobid_xml":"https://content.openalex.org/works/W4391879547.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W2102461774","https://openalex.org/W2226712470","https://openalex.org/W2274942536","https://openalex.org/W2517675534","https://openalex.org/W2766023905","https://openalex.org/W2943489262","https://openalex.org/W3001120382","https://openalex.org/W3004200120","https://openalex.org/W3006513842","https://openalex.org/W3008513590","https://openalex.org/W3032292838","https://openalex.org/W3069119239","https://openalex.org/W3087526660","https://openalex.org/W3200090243","https://openalex.org/W4361005029"],"related_works":["https://openalex.org/W4361005029","https://openalex.org/W2891173371","https://openalex.org/W4317435947","https://openalex.org/W3214492409","https://openalex.org/W2970848930","https://openalex.org/W3017304578","https://openalex.org/W4226111115","https://openalex.org/W3156838311","https://openalex.org/W3214672817","https://openalex.org/W3095197701"],"abstract_inverted_index":{"Evasion":[0],"of":[1,11,23,51,60,112,127,162],"apoptosis":[2,24,172],"is":[3,34,120],"crucial":[4],"for":[5,115,122],"the":[6,21,38,49,58,71,124,163],"growth,":[7],"survival":[8],"and":[9,42,54,56,97,173],"chemoresistance":[10],"many":[12],"cancer":[13],"types,":[14],"including":[15],"acute":[16],"myeloid":[17],"leukemia":[18],"(AML);":[19],"thus,":[20],"reactivation":[22],"can":[25,147,169],"be":[26],"exploited":[27],"as":[28,77],"a":[29,67,78],"therapeutic":[30],"approach.":[31],"Apoptosis":[32],"induction":[33],"mainly":[35],"controlled":[36],"by":[37],"balance":[39],"between":[40],"anti-apoptotic":[41,72,143],"pro-apoptotic":[43],"BCL2":[44,144],"family":[45,145],"proteins,":[46],"which":[47],"determines":[48],"oligomerization":[50],"effectors":[52],"BAX":[53],"BAK":[55],"thus":[57],"permeabilization":[59],"mitochondrial":[61],"membranes":[62],"[":[63,103,154,181],"1":[64],"].":[65,109,156,183],"Venetoclax,":[66],"selective":[68],"inhibitor":[69],"antagonizing":[70],"protein":[73],"BCL2,":[74],"has":[75],"emerged":[76],"promising":[79],"therapy":[80],"in":[81,87,178],"AML.":[82],"Despite":[83],"high":[84],"response":[85],"rates":[86],"combination":[88,116],"with":[89,118,152],"hypomethylating":[90],"agents,":[91],"some":[92],"patients":[93,99],"display":[94],"upfront":[95],"resistance,":[96],"most":[98],"will":[100],"ultimately":[101],"relapse":[102],"2":[104,155],",":[105,107],"3":[106],"4":[108],"Therefore,":[110],"identification":[111],"synergistic":[113,149],"targets":[114,132],"therapies":[117],"venetoclax":[119,153,176],"important":[121],"improving":[123],"clinical":[125],"application":[126],"this":[128],"drug.":[129],"Several":[130],"potential":[131],"have":[133],"been":[134],"revealed.":[135],"For":[136],"instance,":[137],"inhibiting":[138],"BCLXL":[139],"or":[140],"MCL1,":[141],"two":[142],"members,":[146],"trigger":[148],"anti-tumor":[150],"activity":[151],"We":[157],"also":[158],"reported":[159],"that":[160],"inhibition":[161],"RING-type":[164],"ubiquitin":[165],"E3":[166],"ligase":[167],"MARCH5":[168],"induce":[170],"BAX/BAK-dependent":[171],"lead":[174],"to":[175],"sensitization":[177],"AML":[179],"cells":[180],"5":[182]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-02-17T00:00:00"}